The George Institute For Global Health
United Kingdom

News and Events

The best way to deliver end-of-life care is an issue that’s grappled with every day when caring for patients in Intensive Care Units (ICU).

Media release: 

A new pill designed to reduce the devastating toll of heart disease and stroke in Australia and around the world received a $4.5 million boost today.

The George Institute for Global Health recently brought together the collaborators from the NHMRC funded Global Alliance for Chronic Disease project on ‘Cost Effectiveness of Salt Reduction Strategies in the Pacific Islands’ at a meeting in Sydney.

On May 28, the ‘Salt Substitute and Stroke Study (SSaSS) Annual Meeting 2016’ was held in Fengcheng of Liaoning province, a remote study site of SSaSS trial in northeastern China. This year, over 50 participants joined the meeting to report the progress of the study and exchange experiences. Participants included Principal Investigators from China and Australia, local Investigators, Project Coordinators, and experts from provincial study centers.

The George Institute welcomes the US Food and Drug Administration's recent announcement of their draft voluntary reduction targets for the food industry to reduce the amount of sodium and salt in American packaged foods and restaurants.

Media release: 

Preliminary findings from a new research program called the   Worker Health and Efficiency (WE) Program reveal that providing Water, Rest and  Shade  (WRS) to workers in extremely hot environments like India can mitigate the ill effects of heat.

Media release: 

New research from The George Institute for Global Health and the University of Sydney has found that opioid painkillers, a common treatment for low back pain, provide minimal benefit.

Media release: 

People suffering from heart failure should be given the flu vaccine, according to new research from The George Institute for Global Health.

Media release: 

A medication used to treat one of the most common causes of kidney failure reduced the risks of kidney function loss or kidney failure by two thirds, according to a new study.

Research by The George Institute for Global Health which revealed paracetamol does not relieve back pain has been highlighted as one of the top 20 studies of 2015 for GPs.